— GLOBALCORE Academy · Certification Program · CPD-accredited

Study Start-Up & Site Activation: Contracts & Budgets (ICH-GCP) Certification Program

A Contracts & Budgets–focused approach to an aligned Regional Clinical Trial Master Contract Model — with the result being fast, predictable site initiation. Built on ICH-GCP E6(R3), ICH E8(R1), TransCelerate CTA models, FDA 21 CFR 50/54/56/312, EU CTR 536/2014, MHRA, and the SCRS/ACRP site-activation playbook.

  • Regional Master Contract Model — the operating system threaded through all 16 modules and the capstone
  • Empirical proof: France + UK pre-aligned contract AND budget = 40–60% sustained cycle reduction; Italy contract-only = 16% temporary and rebounded
  • Activation as a scheduling exercise, not a negotiation — measured in days, not months
  • ICH-GCP E6(R3) (Jan 2025) quality-by-design and risk-proportionate principles applied module-by-module
  • Hands-on master CTA deployment, master budget bands, FMV defense, and the Master Deviation Log
  • Regulatory submission playbooks: FDA IND/IDE, EU CTIS, MHRA CTA, GCC and Africa national authorities — filed in parallel under the master
  • Capstone — activate a real site off the master and defend it as a scheduling exercise in front of a faculty panel
Empty space, drag to resize

17 modules — end-to-end curriculum

A structured pathway from RWE origins and the 2026 landscape through RWD source selection, modern study design, AI-enabled methods, and evidence-package delivery.

CPD-accredited credential

A portable professional certification recognized by sponsors, CROs, payers, and health systems across North America, EMEA, and Asia-Pacific.

Global curriculum, emerging-markets depth

In addition to US and EU data sources and frameworks, the program covers the GCC, Africa, Southeast Asia, Latin America, and India in detail.

Aligned with 2025–2026 industry standards

Anchored to FDA RWE Demonstration Projects, EMA DARWIN EU integration, ICH M14 (2025), and ICH E9(R1) — target trial emulation, the estimand framework, synthetic control arms, AI-enabled methods, and pharmacoepidemiology.

— Who this is for

Built for the people who activate clinical trial sites

Clinical operations leaders, study start-up specialists, site activation managers, principal investigators, coordinators, contracts and budgets analysts, regulatory affairs leads, and sponsor/CRO/SMO clinical operations teams — building the contract, budget, and regulatory capability that turns interest into First Patient In.
Study start-up and site activation managers (sponsor, CRO, and SMO).
Clinical operations leads, project managers, and clinical trial managers.
Principal investigators, sub-investigators, and site medical directors.
Clinical research coordinators and lead coordinators owning regulatory binders.
Contracts and budgets analysts, contract managers, and outsourcing leads.

Regulatory affairs specialists submitting to FDA, EMA, MHRA, EU CTIS, GCC, and African authorities.

Site directors, research administrators, and hospital research-office leadership.

Biotech and emerging sponsor teams running their first multi-country activation.

— Standards & frameworks

Built on the standards that govern clinical research

The Regional Master Contract Model is not a proprietary framework. It is operationalized directly on the regulations, guidelines, industry templates, and site-activation playbooks that already govern global clinical research. Every module of this program cites the underlying standard — and shows how the master contract and master budget make compliance faster, not slower.

ICH-GCP E6(R3) (January 2025)

The 13 GCP principles, sponsor/investigator responsibilities, essential documents (Section 8), and risk-proportionate quality management (Section 5) — operationalized in every module.

ICH E8(R1)

Quality-by-design and critical-to-quality factors — designed into the master contract architecture and the master budget from kickoff.

TransCelerate BioPharma CTA models

The regional master baseline for clinical trial agreements, vendor MSAs, and TMF reference structure.

FDA 21 CFR Part 50, Part 54, Part 56, and Part 312

The US regulatory anchor for IND submissions, IRB packages, investigator credentialing, and informed-consent execution under the master.

EU Clinical Trials Regulation 536/2014 and CTIS

Master-compatible Part I and Part II, single-submission workflow, and EU-wide assessment under the master framework.

MHRA Combined Review and UK CTA

Master-aligned submission strategy that runs in parallel with EU, US, GCC, and APAC filings.

SCRS site-activation playbook

Society for Clinical Research Sites — the site-facing workflow, selection toolkit, SIV checklist, and budget template integrated with the master.

ACRP competency framework

Association of Clinical Research Professionals — the five-domain professional standard the certification maps to.

— The approach

Study Start-Up & Site Initiation — done right

The backbone of this program is a Contracts & Budgets–focused approach to an aligned Regional Clinical Trial Master Contract Model. Done right, site initiation becomes a scheduling exercise, not a negotiation.

France · Convention Unique

40–60%

Sustained cycle reduction — pre-aligned contract AND budget.

UK · NIHR mCTA

40–60%

Sustained cycle reduction — pre-aligned contract AND budget.

Italy · contract template only

16%

Temporary improvement that rebounded — no budget alignment.

The five tools you'll build and use throughout the course

Master Contract Architecture

Introduced in Module 1, applied in every module after.

Master Deviation Log

Built in Module 3, populated through Modules 4–14, defended in Module 15.

Master Glossary

Module 0 reference document, referenced throughout the program.

Cycle-Time Dashboard

Module 0 metric, tracked module by module against the master.

9-Country Activation Case File

Opened in Module 0, advanced every module, closed in Module 15.

— What you will learn

Outcomes you can demonstrate

Architect a Regional Master Contract Model — governance, architecture, budget bands, and measurement.
Treat every site CTA as a controlled deviation from the master, logged in the Master Deviation Register.
Apply ICH-GCP E6(R3) — quality by design, risk proportionality, and sponsor/investigator roles.
Run a defensible feasibility process scored against master-contract readiness, not just patient availability.
Deploy the master CDA and master CTA on day one — TransCelerate-based, regionally adapted, audit-ready.
Build a regional master budget with FMV-defended bands — bottom-up, per-visit, per-procedure.
Defend master bands with FMV benchmarks, Sunshine Act, and Anti-Kickback considerations.
File parallel regulatory packages — FDA, EU CTIS, MHRA, GCC, African NRAs, APAC — under one master.
Treat the master contract + master budget as the cornerstone Section 8 record in ISF and TMF.
Submit IRB/IEC packages citing master indemnification and subject-injury language by reference.
Schedule the SIV the day IRB approval lands — because contract and budget are already executed.
Forecast FPI using master-aligned vs non-aligned site predictability math.
Bring vendor MSAs (central lab, IRT, ePRO, imaging, courier, pharmacy depot) under the master.
Run site payments against master milestones — not bespoke schedules.
Apply RBQM with master-contract compliance as a critical-to-quality dimension.
Walk inspectors through one coherent regional posture — not 47 site-specific stories.

— A look inside the program

Study Start-Up & Site Activation

Master contracts, budgets, and site activation with ICH-GCP best practices.
Inside the RWE classroom
Live methodology walkthroughs

Course Curriculum

— Standards & frameworks

Built on the standards that govern clinical research

The Regional Master Contract Model is not a proprietary framework. It is operationalized directly on the regulations, guidelines, industry templates, and site-activation playbooks that already govern global clinical research. Every module of this program cites the underlying standard — and shows how the master contract and master budget make compliance faster, not slower.

Regional Master Contract Model as a discipline

The only certification built around an aligned Regional Master Contract Model as a Contracts & Budgets discipline — not a footnote.

Empirical proof baked in

France/UK pre-aligned C&B = 40–60% sustained reduction; Italy contract-only = 16% temporary — taught as a formal lesson.

Master Deviation Log threaded through

Master Deviation Log threaded through
Introduced in Module 1, populated through Modules 4–15, defended in the Capstone — never an attachment.

ICH-GCP E6(R3) (Jan 2025) applied

Quality by design and risk proportionality applied module by module — not just referenced.

Six regions, one master

FDA, EU CTIS, MHRA, GCC, Africa, and APAC — filed in parallel under one operating system.

Capstone defended, not graded

Activation defended as a scheduling exercise in front of a faculty review panel — not an exam-only credential.

Master CTA deployment workshop

Uses the TransCelerate model with a deviation log, not a redline war.

Master budget build

Build FMV-defended regional bands bottom-up from a real Schedule of Events.

Inspector-perspective readiness

Inspection-readiness is taught from the inspector’s perspective — one coherent regional posture.
Empty space, drag to resize

— Competitively superior

Why this program is competitively superior

Pair, do not replace. This program is operational, not role-based. Pair it with ACRP CCRA/CCRC, SOCRA CCRP, or SCRS for full role coverage — it teaches the operating system those credentials reference but do not build.

  • Only program that teaches the Regional Master Contract Model as a dedicated module — not a footnote or template attachment

  • Only program with the France/UK/Italy empirical proof taught as a formal lesson — not just marketed
  • Only program that covers FDA + EU CTIS + MHRA + GCC + Africa + APAC under one operating system
  • Only program where every module ends with a deployable artifact — not just knowledge
  • Only program defended in front of a faculty activation-review panel — not an exam-only credential
  • Only program that treats Contracts AND Budgets as one discipline — not two separate courses
  • Only program built on ICH-GCP E6(R3) + ICH E8(R1) + TransCelerate + SCRS + ACRP frameworks simultaneously

— Assessment & certification

How you earn the credential

  • 17 module quizzes — 70% pass / 2 attempts / randomized question order
  • 1 final cumulative exam — 75% pass / 1 attempt
  • Capstone deliverable: complete site activation packet (feasibility memo + CTA redline + budget + regulatory submission + IRB submission + ISF index + SIV agenda + FPI plan)
  • Capstone defense: faculty activation-review panel
  • CPD-accredited Certificate of Completion issued by GLOBALCORE Academy
Empty space, drag to resize
Empty space, drag to resize

— Learning format

How learners experience the program

  • Self-paced — start anytime, finish on your schedule
  • Video and reading lessons across 16 modules + capstone
  • Worked examples, redline exercises, and editable templates in every module
  • Downloadable templates: feasibility questionnaire, CTA redline, budget builder, regulatory submission tracker, ISF index, SIV agenda, FPI dashboard
  • Quizzes with explanations after every module
  • Faculty activation-review panel capstone
  • Lifetime access to course updates as ICH-GCP, EU CTR, and regional regulations evolve

— Bundles & cross-sell

Bundle this program with related certifications

Clinical Research Associate (CRA)

Pair activation with monitoring.

Clinical Research Coordinator (CRC)

Pair contracts/budgets with site coordination.

Regulatory Affairs (Global, GCC, Africa)

Pair start-up with full regulatory lifecycle.

Decentralized Clinical Trials (DCT)

Pair activation with hybrid/remote site models.

Medical Writing & Scientific Publications

Publish what your activated sites produce.

Frequently asked questions

What is the Regional Master Contract Model and why is this course built around it?

An aligned Regional Master Contract Model is a Contracts & Budgets discipline — pre-negotiated contract language and pre-aligned budget bands deployed across a region. Done right, site initiation becomes a scheduling exercise rather than a negotiation. France (Convention Unique) and the UK (NIHR mCTA) achieved 40–60% sustained cycle reductions by aligning contract AND budget. Italy's contract-only model gained only 16% temporarily before rebounding. This program teaches the discipline that produces the durable result.

Who is this course for?

Clinical operations leaders, study start-up specialists, site activation managers, principal investigators, clinical research coordinators, contracts and budgets analysts, regulatory affairs leads, site directors, and sponsor/CRO/SMO clinical operations teams responsible for moving a trial from feasibility to First Patient In.

Is the program CPD-accredited?

Yes. Learners receive a CPD-accredited Certificate of Completion from GLOBALCORE Academy.

Does this prepare me for ACRP, SOCRA, or SCRS certifications?

It complements those role-based certifications by focusing on the hands-on contract, budget, and regulatory workflow. Many learners use this program as applied training alongside ACRP CCRA/CCRC, SOCRA CCRP, or SCRS certification.

Does it cover ICH-GCP E6(R3)?

Yes. The program is built on ICH-GCP E6(R3) (Jan 2025), including the new emphasis on quality by design, risk proportionality, and sponsor quality management.

Which regulatory regions are covered?

FDA (US), EU CTIS, MHRA (UK), Health Canada, GCC authorities (UAE MOHAP/DHA/SCHS/DOH, Saudi SFDA, Kuwait MOH, Qatar MOH, Bahrain NHRA, Oman MOH), African NRAs (Egypt EDA, South Africa SAHPRA, Kenya PPB, Nigeria NAFDAC), and APAC (Singapore HSA, Japan PMDA, China NMPA, Korea MFDS, India CDSCO).

Will I get editable templates I can use immediately?

Yes. Templates include feasibility questionnaire, CTA redline, bottom-up budget builder, regulatory submission tracker, ISF index, SIV agenda, and an FPI predictability dashboard.

Is the course updated when ICH-GCP or EU CTR changes?

Yes. Lifetime access includes updates as ICH-GCP, EU CTR, MHRA, FDA, and regional regulations evolve.

What do I submit for the capstone?

A complete site activation packet: feasibility memo, CTA redline, bottom-up budget with FMV defense, regulatory submission package, IRB/IEC submission, ISF index against ICH-GCP E6(R3) Section 8, SIV agenda and training plan, FPI predictability plan, and an inspection-readiness self-assessment. You defend the packet in front of a faculty activation-review panel.

Bundle offer

Enroll today

Activate the site. Earn the trial.

Master the contract, budget, and regulatory workflow that turns a feasibility yes into a green-lit First Patient In. Built on ICH-GCP E6(R3), TransCelerate, and a six-region regulatory map — defended in front of a faculty activation-review panel.